12:00 AM
 | 
Dec 05, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Human platelet antigen-1a regulatory update

The European Commission granted Orphan Drug designation for Prophylix's human platelet antigen-1a (HPA-1a) immunoglobulin to prevent fetal and...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >